Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of a Novel Imaging Based Complex Diagnostic and Therapeutic Pathway Intervention for Men Who Fail Radiotherapy for Prostate Cancer.

NCT01883128 is registered in ClinicalTrials.gov with University College London Hospitals as lead sponsor.

NCT NCT01883128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01883128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of a Novel Imaging Based Complex Diagnostic and Therapeutic Pathway Intervention for Men Who Fail Radiotherapy for Prostate Cancer.
Lead sponsor
University College London Hospitals
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2014
Completion date
October 31, 2019
Enrollment
177 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

progression of prostate cancer